[EN] A COMPOSITION COMPRISING SELEGELINE, PROCAINE, VINPOCETINE, TRIMETHYLGLYCINEAN AND A N-GABA INGREDIENT FOR TREATING NEURODEGENERATIVE DISORDERS<br/>[FR] COMPOSITION CONTENANT DE LA SELEGILINE, DE LA PROCAINE, DE LA VINPOCETINE, UN DERIVE DE DU TRIMETHYLGLYCINE ET UN INGREDIENT N-GABA POUR LE TRAITEMENT DE TROUBLES NEURODEGENERATIFS
申请人:UNIFUND CORP LTD
公开号:WO2004032916A1
公开(公告)日:2004-04-22
Neuro-metabolic and endocrine-function regulating/modulating compositions, are disclosed. The compositions of the present invention comprise Selegiline Hydrochloride, Procaine Hydrochloride, Vinpocetine, trimethylglycine, and an ingredient selected from a group consisting of N-nicotinoyl-gamma-aminobutyric acid (N-GABA), niacin, niacinamide, gamma-aminobutyric acid (GABA), and combinations thereof. Comopositions may be used for treating neuro-degenerative conditions, inflammatory processes, depression, vascular dementia and Alzheimer’s disease, digestive disorders; for autoimmune enhancement; for reducing jet lag, for decreasing hormonal inbalance inmenopausal and post-menopausal women; for improving self-confidence, self-esteem; visual or auditory acuity; aerobic endurance, physical agility, blood circulation and reducing blood pressure and hypertension.